ExcelMale
Menu
Home
What's new
Latest activity
Forums
New posts
Search forums
What's new
New posts
Latest activity
Videos
Lab Tests
Doctor Finder
Buy Books
About Us
Men’s Health Coaching
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Navigation
Install the app
Install
More options
Contact us
Close Menu
Forums
Testosterone Replacement, Low T, HCG, & Beyond
Testosterone Basics & Questions
TRT increasing blood pressure?
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="Nelson Vergel" data-source="post: 197439" data-attributes="member: 3"><p>"</p><p>The study found that small- and large-artery elasticity, measured via EndoPAT testing, was reduced among case patients compared to control persons, even after adjustment for differences in systolic blood pressure, resulting in a significantly lower EdoPAT ratio for case patients (0.8 vs 2.7) ― an indication of endothelial dysfunction (<em>P </em>< .00101).</p><p></p><p>The vast majority of participants who had increased cardiac risk, as determined on the basis of EndoPAT ratio levels, would not have been considered at risk on the basis of Framingham Risk Scores, she noted.</p><p></p><p></p><p>Vascular function did not seem to differ with respect to whether women had received chemotherapy, radiation, or had left- or right-sided cancer. Among the AIs, anastrozole was associated with a significantly greater reduction in large-artery elasticity in comparison with exemestane and letrozole. "There was no association between length of time on an AI and EndoPAT ratio," she said.</p><p></p><p>Not surprisingly, median <a href="https://reference.medscape.com/drug/estrace-vivelle-dot-estradiol-342766" target="_blank">estradiol</a> levels were significantly lower in AI-treated women compared to control persons (2 vs 15 pg/mL)."</p><p></p><p>[URL unfurl="true"]https://www.medscape.com/viewarticle/873159[/URL]</p></blockquote><p></p>
[QUOTE="Nelson Vergel, post: 197439, member: 3"] " The study found that small- and large-artery elasticity, measured via EndoPAT testing, was reduced among case patients compared to control persons, even after adjustment for differences in systolic blood pressure, resulting in a significantly lower EdoPAT ratio for case patients (0.8 vs 2.7) ― an indication of endothelial dysfunction ([I]P [/I]< .00101). The vast majority of participants who had increased cardiac risk, as determined on the basis of EndoPAT ratio levels, would not have been considered at risk on the basis of Framingham Risk Scores, she noted. Vascular function did not seem to differ with respect to whether women had received chemotherapy, radiation, or had left- or right-sided cancer. Among the AIs, anastrozole was associated with a significantly greater reduction in large-artery elasticity in comparison with exemestane and letrozole. "There was no association between length of time on an AI and EndoPAT ratio," she said. Not surprisingly, median [URL='https://reference.medscape.com/drug/estrace-vivelle-dot-estradiol-342766']estradiol[/URL] levels were significantly lower in AI-treated women compared to control persons (2 vs 15 pg/mL)." [URL unfurl="true"]https://www.medscape.com/viewarticle/873159[/URL] [/QUOTE]
Insert quotes…
Verification
Post reply
Share this page
Facebook
Twitter
Reddit
Pinterest
Tumblr
WhatsApp
Email
Share
Link
Sponsors
Forums
Testosterone Replacement, Low T, HCG, & Beyond
Testosterone Basics & Questions
TRT increasing blood pressure?
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top